Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and Immunogenicity of FluvalAB Influenza Vaccine in Adults and Elderly
2010-021071-83Phase 4Completed
- Sponsor
- Omninvest
- Start
- Jun 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of influenza A vaccine + influenza B vaccine in influenza (2 arms), sponsored by Omninvest. Primary endpoints: Seroconversion ratio in adults, Seroconversion ratio in elderly and 1 more. Started Jun 2010; status: completed.
02
Drugs
influenza A vaccine + influenza B vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2010-021071-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021071-83.